5-Minute Journal Club — SABCS 2010 Presentations

Please click each issue for edition topic links.

San Antonio Highlights: When Should Patients with Metastatic Breast Cancer Be Rebiopsied? And More... Issue 8 — March 21, 2011 — Current Edition

Lenalidomide with Low- or High-Dose Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma (MM)

Lenalidomide with Low- or High-Dose Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma (MM)

Bortezomib-Based Maintenance Therapy for Elderly Patients with Newly Diagnosed Multiple Myeloma (MM)

Bortezomib-Based Maintenance Therapy for Elderly Patients with Newly Diagnosed Multiple Myeloma (MM)

Carfilzomib/Lenalidomide/Dexamethasone (CRd) as Initial Therapy for Patients with Newly Diagnosed Multiple Myeloma (MM)

Carfilzomib/Lenalidomide/Dexamethasone (CRd) as Initial Therapy for Patients with Newly Diagnosed Multiple Myeloma (MM)

5-Minute Journal Club — ASH 2010 Presentations

Please click each issue for edition topic links.

ASH Highlights: MDS 2011 — The Future Ain't What It Used to Be
Issue 8 — March 29, 2011 — Current Edition

Go directly to our slides and commentary on:

Tolerance and Response to Initial Systemic Therapy in Younger and Older Patients with Multiple Myeloma: A Cross-Sectional Case Survey with 276 Unselected Recent Cases in the Practices of US-Based Medical Oncologists

Tolerance and Response to Initial Systemic Therapy in Younger and Older Patients with Multiple Myeloma: A Cross-Sectional Case Survey with 276 Unselected Recent Cases in the Practices of US-Based Medical Oncologists.
N Love, MD; S Lonial, MD; K Anderson, MD; R Fonseca, MD; K Ziel, PhD; M Elder, BBA; D Paley, BA; A Asnis-Alibozek, MPAS, PA-C

Lenalidomide with Low- or High-Dose Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma (MM)

Bortezomib-Based Maintenance Therapy for Elderly Patients with Newly Diagnosed Multiple Myeloma (MM)

Lenalidomide Maintenance for Patients with Newly Diagnosed Multiple Myeloma (MM) or MM in the Post-TransplantSetting

Carfilzomib/Lenalidomide/Dexamethasone (CRd) as Initial Therapy for Patients with Newly Diagnosed Multiple Myeloma (MM)

Module III: Dr Robert Dreicer

Cancer Educators Slide Library: Management of Dermatologic Toxicities

Module II: Dr Stephen Freedland

PCUTT — Module I: Dr Judd W Moul

Syndicate content